Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

150 companies

Ticker	Company	Revenue	Net income	Net margin	Return on equity	Revenue growth ▴	Diluted EPS
CRDF	Cardiff Oncology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$593.0K	-$45.85M	n/m	-101.0%	-13.2%	-$0.69
DYAI	Dyadic International Inc Manufacturing · Year ended 2025-12-31 · USD	$3.09M	-$7.36M	-238.3%	-597.6%	-11.6%	-$0.23
VIVS	VivoSim Labs, Inc. Manufacturing · Year ended 2026-03-31 · USD	$131.0K	-$13.84M	n/m	n/a	-9.0%	-$5.35
VIR	Vir Biotechnology, Inc. Manufacturing · Year ended 2025-12-31 · USD	$68.56M	-$437.99M	-638.9%	-57.2%	-7.6%	-$3.16
ATRA	Atara Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$120.77M	$32.69M	27.1%	n/a	-6.3%	$2.57
FENC	Fennec Pharmaceuticals Inc. Manufacturing · Year ended 2025-12-31 · USD	$44.64M	-$9.74M	-21.8%	-27.5%	-6.1%	-$0.34
PLX	Protalix BioTherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$52.74M	-$6.60M	-12.5%	-13.7%	-1.2%	-$0.08
TECH	Bio-Techne Corp Manufacturing · Year ended 2026-06-30 · USD	$1.22B	$181.86M	15.0%	8.6%	-0.4%	$1.16
CCCC	C4 Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$35.95M	-$104.99M	-292.1%	-40.9%	1.0%	-$1.27
BIIB	Biogen Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.89B	$1.29B	13.1%	7.1%	2.2%	$8.79
GILD	Gilead Sciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$29.44B	$8.51B	28.9%	37.6%	2.4%	$6.78
CSBR	Champions Oncology, Inc. Manufacturing · Year ended 2026-04-30 · USD	$59.42M	-$1.18M	-2.0%	-29.8%	4.4%	-$0.08
QGEN	Qiagen N.V. Manufacturing · Year ended 2025-12-31 · USD	$2.09B	$424.88M	20.3%	11.2%	5.7%	$1.94
EXEL	Exelixis, Inc. Manufacturing · Year ended 2026-01-02 · USD	$2.32B	$782.57M	33.7%	36.2%	7.0%	$2.78
OCGN	Ocugen, Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.41M	-$67.85M	n/m	n/a	8.8%	n/a
AMGN	Amgen Inc Manufacturing · Year ended 2025-12-31 · USD	$36.75B	$7.71B	21.0%	89.1%	10.0%	$14.23
AGEN	Agenus Inc Manufacturing · Year ended 2025-12-31 · USD	$114.20M	-$3.08M	-2.7%	n/a	10.4%	$0.00
CRBU	Caribou Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$11.16M	-$148.12M	n/m	-121.2%	11.7%	-$1.59
ZEOX	Zeo ScientifiX, Inc. Manufacturing · Year ended 2025-10-31 · USD	$5.20M	-$5.52M	-106.2%	n/a	12.5%	-$0.86
RGEN	Repligen Corp Manufacturing · Year ended 2025-12-31 · USD	$738.26M	$48.89M	6.6%	2.3%	16.4%	$0.86
VCEL	Vericel Corp Manufacturing · Year ended 2025-12-31 · USD	$276.26M	$16.52M	6.0%	4.7%	16.5%	$0.32
TSHA	Taysha Gene Therapies, Inc. Manufacturing · Year ended 2025-12-31 · USD	$9.77M	-$109.00M	n/m	-44.1%	17.3%	-$0.34
ADMA	ADMA Biologics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$510.17M	$146.93M	28.8%	30.8%	19.6%	$0.60
TWST	Twist Bioscience Corp Manufacturing · Year ended 2025-09-30 · USD	$376.57M	-$77.67M	-20.6%	-16.4%	20.3%	-$1.30
NBIX	Neurocrine Biosciences Inc Manufacturing · Year ended 2025-12-31 · USD	$2.86B	$478.60M	16.7%	14.7%	21.4%	$4.67

Rows per page: 2550 100